Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

NCT00247663 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Women With Advanced Breast Cancer

Interventions

DRUG: Letrozole

Sponsor

Novartis Pharmaceuticals

Collaborators

[object Object]